Adicet Bio (ACET) Other Non Operating Income (2017 - 2026)
Adicet Bio (ACET) posted quarterly Other Non Operating Income of $7000.0 for Q1 2026, up 158.33% year-over-year from $2709.7 in Q1 2025, and up 105.38% quarter-over-quarter from -$130000.0 in Q4 2025.
Adicet Bio (ACET) Other Non Operating Income (2017 - 2026) Analysis & Trends
Adicet Bio's Other Non Operating Income history runs 10 years deep, the most recent figure standing at $7000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 158.33% year-over-year to $7000.0; the TTM figure through Mar 2026 stood at -$410000.0 (down 145.51% YoY), while the FY2025 annual figure was -$430000.0, down 98.16% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $7000.0, up from -$130000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $7000.0 in Q1 2026, with the low at -$463000.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is -$102000.0 (2022), against an average of -$125352.9.
- The sharpest annual moves came in 2022 and 2026: Other Non Operating Income plunged 2450.0% in 2022, then soared 158.33% in 2026.
- Adicet Bio's Other Non Operating Income stood at -$463000.0 in 2022, then jumped by 78.19% to -$101000.0 in 2023, then soared by 50.5% to -$50000.0 in 2024, then plunged by 160.0% to -$130000.0 in 2025, then soared by 105.38% to $7000.0 in 2026.
- Business Quant data shows ACET's Other Non Operating Income at $7000.0 in Q1 2026, -$130000.0 in Q4 2025, and -$64000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -60,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | -130,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Jun 30, 2025 | -223,000.00 |
| Mar 31, 2025 | -12,000.00 |
| Dec 31, 2024 | -50,000.00 |
| Sep 30, 2024 | -54,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Mar 31, 2024 | -61,000.00 |
| Dec 31, 2023 | -101,000.00 |
| Sep 30, 2023 | -142,000.00 |
| Jun 30, 2023 | -124,000.00 |
| Mar 31, 2023 | -206,000.00 |
| Dec 31, 2022 | -463,000.00 |
| Sep 30, 2022 | -217,000.00 |
| Jun 30, 2022 | -138,000.00 |
| Mar 31, 2022 | -102,000.00 |
| Dec 31, 2021 | -294,000.00 |
| Sep 30, 2021 | -246,000.00 |